Literature DB >> 28844973

In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?

Priyanka Jain1, R S Pawar1, R S Pandey2, Jitender Madan3, Sulakshna Pawar4, P K Lakshmi1, M S Sudheesh5.   

Abstract

One of the unmet challenges in nanotechnology is to understand and establish the relationship between physicochemical properties of nanoparticles (NPs) and its biological interactions (bio-nano interactions). However, we are still far from assessing the biofate of NPs in a clear and unquestionable manner. Recent developments in the area of bio-nano interface and the understanding of protein corona (PC) has brought new insight in predicting biological interactions of NPs. PC refers to the spontaneous formation of an adsorbed layer of biomolecules on the surface of NPs in a biological environment. PC formation involves the spatiotemporal interplay of an intricate network of biological, environmental and particle characteristics. NPs with its PC can be viewed as a biological entity, which interacts with cells and barriers in a biological system. Recent studies on the bio-nano interface have revealed biological signatures that participate in cellular and physiological bioprocesses and control the biofate and toxicity of NPs. The ability of in-vitro derived parameters to forecast in-vivo consequences by developing a mathematical model forms the basis of in-vitro in-vivo correlation (IVIVC). Understanding the effect of bio-nano interactions on the biological consequences of NPs at the cellular and physiological level can have a direct impact on the translation of future nanomedicines and can lead to the ultimate goal of developing a mathematical IVIVC model. The review summarizes the emerging paradigms in the field of bio-nano-interface which clearly suggests an urgent need to revisit existing protocols in nanotechnology for defining the physicochemical correlates of bio-nano interactions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bio-nano interface; Cell uptake; IVIVC; Inflammation; Nanoparticles; Physicochemical property; Protein corona; Targeting

Mesh:

Substances:

Year:  2017        PMID: 28844973     DOI: 10.1016/j.biotechadv.2017.08.003

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  18 in total

Review 1.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 2.  In vitro dissolution considerations associated with nano drug delivery systems.

Authors:  Ritu Gupta; Yuan Chen; Huan Xie
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-06-15

Review 3.  Preparing (Metalla)carboranes for Nanomedicine.

Authors:  Marta Gozzi; Benedikt Schwarze; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2021-03-19       Impact factor: 3.466

4.  Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept study.

Authors:  Wenhao Wang; Zhengwei Huang; Yanbei Li; Wenhua Wang; Jiayu Shi; Fangqin Fu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2020-10-29       Impact factor: 11.413

Review 5.  The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines.

Authors:  C Gutiérrez-Lovera; A J Vázquez-Ríos; J Guerra-Varela; L Sánchez; M de la Fuente
Journal:  Genes (Basel)       Date:  2017-11-28       Impact factor: 4.096

6.  Targeting Tumorigenicity of Breast Cancer Stem Cells Using SAHA/Wnt-b Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles.

Authors:  Azam Shamsian; Mohammad Reza Sepand; Marziye Javaheri Kachousangi; Tahereh Dara; Seyed Nasser Ostad; Fatemeh Atyabi; Mohammad Hossein Ghahremani
Journal:  Int J Nanomedicine       Date:  2020-06-11

Review 7.  Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices.

Authors:  Francisca Villanueva-Flores; Andrés Castro-Lugo; Octavio T Ramírez; Laura A Palomares
Journal:  Nanotechnology       Date:  2019-11-26       Impact factor: 3.874

Review 8.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

9.  Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part II. Toxicity, Pharmacokinetics and Biodistribution.

Authors:  Anna Lankoff; Malwina Czerwińska; Rafał Walczak; Urszula Karczmarczyk; Kamil Tomczyk; Kamil Brzóska; Giulio Fracasso; Piotr Garnuszek; Renata Mikołajczak; Marcin Kruszewski
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  Gel with silver and ultrasmall iron oxide nanoparticles produced with Amanita muscaria extract: physicochemical characterization, microstructure analysis and anticancer properties.

Authors:  Olena Ivashchenko; Łucja Przysiecka; Barbara Peplińska; Marcin Jarek; Emerson Coy; Stefan Jurga
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.